BTC Digital Ltd. Announces Closing of $20.0 Million Underwritten Public Offering
SINGAPORE, Dec. 9, 2024 /PRNewswire/ — BTC Digital Ltd. (NASDAQ: BTCT) (the “Company”), a blockchain technology company, today announced the closing... Read more.
FirstEnergy Eclipses 100,000 Trees Planted and Donated
Milestone comes after surpassing 2024 goal of 25,000 donated trees AKRON, Ohio, Dec. 9, 2024 /PRNewswire/ — As part of its commitment to the environment and... Read more.
Radius Global Market Research Announces Acquisition of 7th Sense
The new partnership supports Radius’s insights-driven approach by integrating 7th Sense’s focus on intuitive, sense-based consumer research. NEW YORK,... Read more.
Vance Street Capital Partners With System Seals
Growth investment poised to enhance commercial strategy while supporting strategic M&A for System Seals, a leading provider of highly-engineered sealing solutions... Read more.
Exchange to Honor the Late LTG Arthur Gregg with Quality-of-Life Force Multiplier Award
Army trailblazer’s family will accept award during presentation at the 125th Army-Navy Game DALLAS, Dec. 9, 2024 /PRNewswire/ — The Exchange will honor... Read more.
CoreWeave and Dell Technologies Extend Relationship to Deliver AI at Scale
CoreWeave signs strategic agreement with Dell to support next generation AI innovation CoreWeave integrates its Cloud Services Platform with the Dell AI Factory... Read more.
CenterGate Capital Announces Partnership with Leading Provider of Eyewear Frames
PORT CHESTER, N.Y., Dec. 9, 2024 /PRNewswire/ — CenterGate Capital (“CenterGate”), an Austin-based private equity investment firm, announced today... Read more.
Helix Advisory and ZignaAI Partner to Introduce Cutting-Edge Payer AI Technology to Providers
CINCINNATI, Dec. 9, 2024 /PRNewswire/ — Helix Advisory, a leading provider of revenue cycle management solutions, and ZignaAI, an innovator in AI-powered... Read more.
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington’s Disease Patient Trial
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company’s ongoing Phase 1 trial in patients with Huntington’s... Read more.
What FlyLink Ensures for Consumers: Shop Confidently and Pay Safely Online
Discover how FlyLink ensures safe payments, global accessibility, and reliable products, making your online transaction seamless and worry-free. BEIJING, Dec. 9,... Read more.